AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionEP Wealth Advisors, Inc.
Latest Disclosed Ownership261,651 shares
Latest Disclosed Value $ 56,906,550
EP Wealth Advisors, Inc. reports 1.92% increase in ownership of ABBV / AbbVie Inc.

On May 14, 2026 - EP Wealth Advisors, Inc. filed a 13F-HR form disclosing ownership of 261,651 shares of AbbVie Inc. (US:ABBV) valued at $56,906,476 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 256,734 shares of AbbVie Inc.. This represents a change in shares of 1.92% during the quarter. The current value of the position is $59,454,957 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 261,651 4,917 1.92 56,907 -2.99 0.2795
2026-02-18 2025-12-31 13F ABBVIE COM 00287Y109 256,734 129,292 101.45 58,661 147.99 0.3048
2025-08-14 2025-06-30 13F ABBVIE COM 00287Y109 127,442 1,314 1.04 23,656 -10.49 0.1555
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 126,128 21,090 20.08 26,426 41.58 0.2111
2025-02-14 2024-12-31 13F ABBVIE COM 00287Y109 105,038 4,691 4.67 18,665 -5.81 0.1523
2024-11-15 2024-09-30 13F ABBVIE COM 00287Y109 100,347 9,298 10.21 19,816 26.90 0.1703
2024-08-19 2024-06-30 13F ABBVIE COM 00287Y109 91,049 2,439 2.75 15,617 -3.22 0.1659
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 88,610 3,439 4.04 16,136 22.25 0.1886
2024-02-28 2023-12-31 13F ABBVIE COM 00287Y109 85,171 -2,167 -2.48 13,199 1.38 0.1683
2023-11-24 2023-09-30 13F ABBVIE COM 00287Y109 87,338 81,488 1,392.96 13,019 6.42 0.2019
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 5,850 -89,404 -93.86 12,234 -19.41 0.1764
2023-06-05 2023-03-31 13F ABBVIE COM 00287Y109 95,254 4,657 5.14 15,181 3.68 0.2611
2023-06-12 2022-12-31 13F ABBVIE COM 00287Y109 90,597 -3,378 -3.59 14,641 16.09 0.2638
2022-12-02 2022-09-30 13F ABBVIE COM 00287Y109 93,975 62,963 203.03 12,612 165.52 0.2860
2022-08-11 2022-06-30 13F ABBVIE COM 00287Y109 31,012 -602 -1.90 4,750 -7.32 0.1070
2022-05-20 2022-03-31 13F ABBVIE COM 00287Y109 31,614 116 0.37 5,125 20.16 0.1125
2022-02-17 2021-12-31 13F ABBVIE COM 00287Y109 31,498 -1,157 -3.54 4,265 21.10 0.1008
2021-11-23 2021-09-30 13F/A-1 ABBVIE COM 00287Y109 32,655 -3,534 -9.77 3,522 -13.59 0.0966
2021-11-16 2021-09-30 13F ABBVIE COM 00287Y109 36,189 0 3,522 0.0966
2021-08-24 2021-06-30 13F ABBVIE COM 00287Y109 36,189 435 1.22 4,076 5.35 0.1130
2021-05-17 2021-03-31 13F ABBVIE COM 00287Y109 35,754 20,870 140.22 3,869 142.57 0.1230
2021-02-18 2020-12-31 13F ABBVIE COM 00287Y109 14,884 4,404 42.02 1,595 73.75 0.0561
2020-11-17 2020-09-30 13F ABBVIE COM 00287Y109 10,480 -532 -4.83 918 -15.08 0.0395
2020-08-14 2020-06-30 13F ABBVIE COM 00287Y109 11,012 -1,114 -9.19 1,081 16.99 0.0462
2020-05-18 2020-03-31 13F ABBVIE COM 00287Y109 12,126 -1,643 -11.93 924 -24.20 0.0452
2020-02-14 2019-12-31 13F ABBVIE COM 00287Y109 13,769 1,363 10.99 1,219 29.82 0.0502
2019-11-18 2019-09-30 13F ABBVIE COM 00287Y109 12,406 -1,059 -7.86 939 -4.09 0.0466
2019-08-27 2019-06-30 13F ABBVIE COM 00287Y109 13,465 4,458 49.49 979 34.85 0.0612
2019-05-20 2019-03-31 13F ABBVIE COM 00287Y109 9,007 533 6.29 726 -7.04 0.0698
2019-02-15 2018-12-31 13F ABBVIE COM 00287Y109 8,474 -495 -5.52 781 -7.90 0.0602
2018-11-15 2018-09-30 13F ABBVIE COM 00287Y109 8,969 4,250 90.06 848 94.05 0.0663
2018-08-14 2018-06-30 13F ABBVIE COM 00287Y109 4,719 -21 -0.44 437 -2.67 0.0412
2018-05-15 2018-03-31 13F ABBVIE COM 00287Y109 4,740 1,389 41.45 449 38.58 0.0434
2018-02-15 2017-12-31 13F ABBVIE COM 00287Y109 3,351 -14 -0.42 324 8.36 0.0342
2017-11-15 2017-09-30 13F ABBVIE COM 00287Y109 3,365 110 3.38 299 26.69 0.0345
2017-08-17 2017-06-30 13F ABBVIE COM 00287Y109 3,255 3,255 236 0.0289
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.